Cargando…

Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have proven cardiovascular benefits in patients with type 2 diabetes (T2D). This self-controlled case series study aims to evaluate whether metformin use and SGLT2i-associated erythrocytosis influence its cardiovascular benefits. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Carlos King Ho, Lau, Kristy Tsz Kwan, Tang, Eric Ho Man, Lee, Chi Ho, Lee, Carmen Yu Yan, Woo, Yu Cho, Au, Ivan Chi Ho, Tan, Kathryn Choon Beng, Lui, David Tak Wai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166572/ https://www.ncbi.nlm.nih.gov/pubmed/35658864 http://dx.doi.org/10.1186/s12933-022-01520-w

Ejemplares similares

Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong
por: Lui, David Tak Wai, et al.
Publicado: (2023)

Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis
por: Lui, David Tak Wai, et al.
Publicado: (2022)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Is metformin a miracle or a menace in COVID‐19 patients with type 2 diabetes?
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study
por: Xiong, Xi, et al.
Publicado: (2023)

Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

A territory‐wide study on the impact of COVID‐19 on diabetes‐related acute care
por: Lui, David Tak Wai, et al.
Publicado: (2020)

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy
por: Schumacher, Kamilya A., et al.
Publicado: (2022)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

Letter to the Editor: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS‑CoV‑2 disease’—prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity
por: Lui, David Tak Wai, et al.
Publicado: (2022)

Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines
por: Lee, Chi-Ho, et al.
Publicado: (2022)

Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
por: Lee, Chi-Ho, et al.
Publicado: (2022)

Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
por: Lui, David T. W., et al.
Publicado: (2023)

The role of PHD2 mutations in the pathogenesis of erythrocytosis
por: Gardie, Betty, et al.
Publicado: (2014)

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Benefits of SGLT2 inhibitors in arrhythmias
por: Gao, Jinghan, et al.
Publicado: (2022)

A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19
por: Lui, David Tak Wai, et al.
Publicado: (2022)

SURPRISING ERYTHROCYTOSIS RESOLUTION AFTER MYOMECTOMY: MYOMATOUS ERYTHROCYTOSIS SYNDROME
por: Couillandre, Pauline, et al.
Publicado: (2023)

Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Concise and Stereodivergent Synthesis of Carbasugars Reveals Unexpected Structure-Activity Relationship (SAR) of SGLT2 Inhibition
por: Ng, Wai-Lung, et al.
Publicado: (2017)

Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
por: Chang, Johnny Yau-Cheung, et al.
Publicado: (2022)

DELIVER: Extending the benefits of SGLT-2 inhibitors
por: Samaan, Kerollos, et al.
Publicado: (2023)

Effect of type 2 diabetes on the inducible degrader of LDL receptor
por: Lam, Sum, et al.
Publicado: (2023)

The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis
por: Xu, Chunmei, et al.
Publicado: (2022)

mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2022)

Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
por: Sim, A Young, et al.
Publicado: (2021)

Incorporation of information diffusion model for enhancing analyses in HIV molecular surveillance
por: Kwan, Tsz Ho, et al.
Publicado: (2020)

Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
por: Wong, Carlos King Ho, et al.
Publicado: (2022)

Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform()
por: Chiang, Valerie, et al.
Publicado: (2021)

Idiopathic erythrocytosis in a patient on chronic hemodialysis
por: Lee, Dong Hyun, et al.
Publicado: (2015)

Genetic Background of Congenital Erythrocytosis
por: McMullin, Mary Frances
Publicado: (2021)

Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: decrements associated with individual complication and number of complications
por: Jiao, Fangfang, et al.
Publicado: (2017)

Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis
por: Kristan, Aleša, et al.
Publicado: (2021)

Myomatous erythrocytosis syndrome: A case report
por: Shu, Xin-Yu, et al.
Publicado: (2022)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

THU338 Risks Of Stroke, Its Subtypes And Atrial Fibrillation Associated With Glucagon-like Peptide 1 Receptor Agonists Versus Sodium-glucose Cotransporter 2 Inhibitors: A Real-world Population-based Study In Hong Kong
por: Lui, David, et al.
Publicado: (2023)

Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now
por: Lee, Chi Ho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9s6tkslgv0tjq5e4ca0fddigf4